Physiology and pathophysiology of the calcium-sensing receptor in the kidney
Tóm tắt
The extracellular calcium-sensing receptor (CaSR) plays a major role in the maintenance of a physiological serum ionized calcium (Ca2+) concentration by regulating the circulating levels of parathyroid hormone. It was molecularly identified in 1993 by Brown et al. in the laboratory of Dr. Steven Hebert with an expression cloning strategy. Subsequent studies have demonstrated that the CaSR is highly expressed in the kidney, where it is capable of integrating signals deriving from the tubular fluid and/or the interstitial plasma. Additional studies elucidating inherited and acquired mutations in the CaSR gene, the existence of activating and inactivating autoantibodies, and genetic polymorphisms of the CaSR have greatly enhanced our understanding of the role of the CaSR in mineral ion metabolism. Allosteric modulators of the CaSR are the first drugs in their class to become available for clinical use and have been shown to treat successfully hyperparathyroidism secondary to advanced renal failure. In addition, preclinical and clinical studies suggest the possibility of using such compounds in various forms of hypercalcemic hyperparathyroidism, such as primary and lithium-induced hyperparathyroidism and that occurring after renal transplantation. This review addresses the role of the CaSR in kidney physiology and pathophysiology as well as current and in-the-pipeline treatments utilizing CaSR-based therapeutics.
Từ khóa
Tài liệu tham khảo
Aida K, 1995, J Clin Endocrinol Metab, 80, 2594
Bringhurst FR, 1998, Williams's Textbook of Endocrinology, 9, 1155
Carling T, 2000, J Clin Endocrinol Metab, 85, 2042
el-Hajj Fuleihan G, 1998, J Clin Endocrinol Metab, 83, 2366
Heath DA, 1994, The Parathyroids, 699
Heath H, 1993, Am J Hum Genet, 53, 193
Hebert SC, 1999, Semin Nephrol, 19, 504
Hebert SC, 2007, The Kidney: Physiology and Pathophysiology, 4, 1785
Kallay E, 2003, Forum Nutr, 56, 188
Khosla S, 1993, J Clin Endocrinol Metab, 76, 715
Knepper MA, 1991, Kidney Int Suppl, 33, S95
Kobayashi M, 1997, J Clin Endocrinol Metab, 82, 2716
Lienhardt A, 2000, J Clin Endocrinol Metab, 85, 1695
Mathias R, 1997, J Bone Miner Res, 12, S326
Nemeth EF, 1998, J Bone Miner Res, 23, S156
Pearce S, 1995, J Bone Miner Res, 10, S176
Rivkees SA, 1992, J Clin Endocrinol Metab, 75, 1514
Strewler GJ, 1994, West J Med, 160, 579
Takaichi K, 1986, Miner Electr Metab, 12, 342